← Back to Screener

Sector: Healthcare
Open in Terminal → MTDLive chart · Key metrics · News · Smart money

Mettler-Toledo International, I

MTD Large Cap

Healthcare · Diagnostics & Research

Updated: Jun 14, 2026, 22:19 UTC

$1,131.49
-0.86% today
52W: $1,023.05 – $1,525.17
52W Low: $1,023.05 Position: 21.6% 52W High: $1,525.17

Price Chart

Key Metrics

P/E Ratio
26.6x
Price-to-Earnings
Forward P/E
22.07x
Forward Price/Earnings
P/S Ratio
5.59x
Price-to-Sales
EV/EBITDA
20.56x
Enterprise Value/EBITDA
Div. Yield
Annual dividend yield
Market Cap
$22.9B
Market Capitalization
Revenue Growth
7.2%
YoY Revenue Growth
Profit Margin
21.4%
Net profit margin
ROE
Return on Equity
Beta
1.26
Market sensitivity
Short Interest
3.89%
% of float sold short
Avg. Volume
182,153
Average daily volume

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Buy
12 analysts
Avg. Price Target
$1,327.83
+17.35% upside
Target Range
$1,194.00 – $1,550.00

About the Company

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also p

Sector: Healthcare Industry: Diagnostics & Research Country: Switzerland Employees: 16,600 Exchange: NYQ

Mettler-Toledo International, I Stock at a Glance

Mettler-Toledo International, I (MTD) is currently trading at $1,131.49 with a market capitalization of $22.9B. The trailing P/E ratio stands at 26.6x, with a forward P/E of 22.07x. The 52-week range spans from $1,023.05 to $1,525.17; the current price is 25.8% below the yearly high. Year-over-year revenue growth stands at +7.2%. The net profit margin stands at 21.4%.

💰 Dividend

Mettler-Toledo International, I currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

12 analysts rate Mettler-Toledo International, I (MTD) on consensus: Buy. The average price target is $1,327.83, implying +17.35% from the current price. Analyst price targets range from $1,194.00 to $1,550.00.

Mettler-Toledo International, I: The Investment Case in Detail

Mettler-Toledo International, I (MTD) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in Switzerland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

The combination of a 59.19% gross margin and 23.29% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Free cash flow is positive and net margins stand at 21.4%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions. Wall Street consensus sits at Buy with an average price target implying roughly 17.35% upside from current levels — analyst sentiment is firmly constructive.

What to Watch Next

  • The forward P/E of 22.07x is meaningfully below the trailing 26.6x — analysts expect earnings to step up; the next earnings release is the test.
  • The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.

Investment Thesis: Strengths & Weaknesses

Strengths
  • Profitable with 21.4% net margin
  • High gross margin of 59.19% — indicates pricing power
  • Analyst consensus: Buy
  • Positive free cash flow
Weaknesses

No significant red flags in current metrics.

Technical Snapshot

50-Day MA
$1,206.62
-6.23% vs. price
200-Day MA
$1,318.13
-14.16% vs. price
Below 52W High
−25.8%
$1,525.17
Above 52W Low
+10.6%
$1,023.05

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

Market Risk (Beta)
1.26 · Elevated
Moves more than the overall market
Short Interest
3.89% · Low
% of float sold short

The data points to market-like volatility.

Trading Data

50-Day MA: $1,206.62
200-Day MA: $1,318.13
Volume: 81,242
Avg. Volume: 182,153
Short Ratio: 3.02
P/B Ratio:
Debt/Equity:
Free Cash Flow: $615M

More Healthcare stocks

Top peers in the same sector — ranked by market cap.

View full Healthcare sector page →

Where can I buy Mettler-Toledo International, I?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Scroll to Top